Depression News and Research

Latest Depression News and Research

SSRIs exhibit anti-inflammatory effects and may provide drug development opportunities for RA

A new study found that fluoxetine (Prozac-) and citalopram (Celexa-) treatment significantly inhibited disease progression of collagen-induced arthritis (CIA) in mice. Research led by Sandra Sacre, Ph.D. from the Brighton and Sussex Medical School (BSMS) in the UK studied the anti-arthritic potential of these drugs, known as selective serotonin reuptake inhibitors (SSRIs), most commonly used to treat depression.

25 Feb 2010

Biochemical link between misery and death discovered

In ongoing work to identify how genes interact with social environments to impact human health, UCLA researchers have discovered what they describe as a biochemical link between misery and death. In addition, they found a specific genetic variation in some individuals that seems to disconnect that link, rendering them more biologically resilient in the face of adversity.

25 Feb 2010

Ten steps to help caregivers take care of themselves

Faced with the need to provide daily care, often to family members with special needs or disabilities, caregivers tend to overlook their own short- and long-term personal and financial needs, putting at risk their own health and security.

24 Feb 2010

Anxiety in German psychosomatic units: Long term extensive experience of treatment

A study published in the current issue of Psychotherapy and Psychosomatics reports on a long term extensive experience of treatment of psychosomatic symptoms related to anxiety in German psychosomatic units.

24 Feb 2010

Religious belief can reduce depression symptoms

Research suggests that religious belief can help protect against symptoms of depression, but a study at Rush University Medical Center goes one step further.

24 Feb 2010

Hudson Health Plan deploys Health Integrated Synergy Targeted Population Management program

Hudson Health Plan, a not-for-profit managed care organization that services New York's Hudson Valley, has selected Health Integrated, Inc., a leading provider of Health Management Solutions, as its partner to provide enhanced care management services for Medicaid members with co-morbid chronic illness.

24 Feb 2010

Combination therapies effective for treating depression

Even after she left her alcoholic, abusive husband behind, Patrice, a nurse in Florida, couldn't summon the energy to keep her house straight, couldn't sleep.

24 Feb 2010

Individuals with higher midlife BMI scores have lower cognitive ability: Study

The adverse affects of being overweight are not limited to physical function but also extend to neurological function, according to research in the latest issue of the Journals of Gerontology Series A: Biological and Medical Sciences (Volume 65A, Number 1).

24 Feb 2010

Depression and stress hormone levels may lead to obesity in girls

Depression raises stress hormone levels in adolescent boys and girls but may lead to obesity only in girls, according to researchers. Early treatment of depression could help reduce stress and control obesity -- a major health issue.

24 Feb 2010

State Round up: Utah struggling with state online health exchange; California cracks down on discount health plans

The Salt Lake Tribune: "Utah lawmakers this year have spared no energy trumpeting their dislike for federal health reform, passing bills asserting states' right to govern themselves. But Utah's own health care fix, an online insurance market called the Utah Health Exchange, has gotten off to a wobbly start. And legislation to repair it, sponsored by Republican House Speaker Dave Clark, came under siege last week. ...The debate left some reform advocates privately wondering if the topic has become too toxic to handle" (Stewart, 2/23).

24 Feb 2010

ViiV Healthcare highlights S/GSK1349572, SELZENTRY and EPZICOM for HIV/AIDS at 17th CROI

At the 17th Conference on Retroviruses and Opportunistic Infections (CROI), ViiV Healthcare presented new data across its broad range of investigational and current medicines for the treatment of HIV/AIDS. Highlighted data at the conference included an oral presentation on the investigational integrase inhibitor, S/GSK1349572, as well as data presentations on SELZENTRY® (maraviroc) and EPZICOM® (abacavir/lamivudine).

24 Feb 2010

NCC, Pfizer provide over 10M units of ReFacto Antihemophilic Factor to underserved hemophilia patients

The National Cancer Coalition (NCC) is pleased to announce its recent collaboration with Pfizer, Inc to provide hemophilia medicines to underserved patients in the developing world. To date, NCC has received more than 10 million international units of ReFacto® Antihemophilic Factor (Recombinant), a therapy used for the treatment and prevention of bleeding in people with hemophilia A, to assist patients who otherwise would have little opportunity for adequate treatment. The value of this donation is more than $13 million, and it will help many hundreds of hemophilia patients around the world.

23 Feb 2010

Behavioral Neuroscience: Adolescents more susceptible to internal and environmental factors

While the otherworldly behavior of teenagers is well documented, University of Pittsburgh researchers have taken a significant step toward finally unraveling the actual brain activity that can drive adolescents to engage in impulsive, self-indulgent, or self-destructive behavior.

23 Feb 2010

Strategies to reduce inappropriate treatment by clinicians

Clinicians may use one of several approaches to deny patient requests for an inappropriate treatment while preserving the physician-patient relationship, according to a report in the February 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

23 Feb 2010

Obecure granted patent covering betahistine with olanzapine for mitigating antipsychotic drug associated weight gain

Obecure Ltd., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., has received notice of allowance from the US Patent Office for its two key patent applications covering methods of use and compositions covering the use of betahistine with olanzapine for the mitigation of the serious weight gain associated as a side effect of the antipsychotic drug.

23 Feb 2010

Role of behavioral health in pediatric IBD: NIHCD awards $500,000 grant to further study

The National Institutes of Health has awarded a two-year development grant to researchers with Hasbro Children's Hospital and the Bradley Hasbro Children's Research Center to better understand the role behavioral health plays in pediatric inflammatory bowel disease (IBD), a condition that causes chronic and painful inflammation in the gastrointestinal tract.

23 Feb 2010

Nation-wide study to assess risk of suicide among men

The introduction of prostate-specific antigen (PSA) testing as a screening tool for early detection of prostate cancer (PCa) in the beginning of the 1990s drastically increased the detection of PCa. The risk of suicide is increased among cancer patients including men with PCa.

23 Feb 2010

ResMed launches S9 sleep apnoea therapy platform in Europe

ResMed, a leading developer, manufacturer, and distributor of sleep and respiratory medical equipment, today introduced its new cutting-edge sleep apnoea therapy platform called the S9 Series in Europe. The S9 Series combines a sleek design with superior functionality and more comfort. Combined climate control and humidification delivers unsurpassed comfort to the patient by controlling both the temperature and humidity that the patient breathes.

From ResMed Corp 22 Feb 2010

HHMI investigator to discuss how brain creates and controls emotions

Scientists know little about how the brain creates and controls emotions - an uncertainty that presents a major obstacle in the effort to develop treatments for emotional disorders. "The study of the brain science of emotion is in its infancy," says Howard Hughes Medical Institute (HHMI) investigator David Anderson, "yet emotional and psychiatric disorders continue to take an enormous toll on human society."

22 Feb 2010

Brain and tissue sample repository to help advance understanding and treatment of psychiatric diseases

Johns Hopkins Children's Center neurovirologist Robert Yolken, M.D., and collaborators from the Stanley Medical Research Institute have developed a large repository of brain and tissue samples to advance the understanding and treatment of bipolar disorder, major depression and schizophrenia.

20 Feb 2010

Depression News and Research

Latest Depression News and Research

SSRIs exhibit anti-inflammatory effects and may provide drug development opportunities for RA

Biochemical link between misery and death discovered

Ten steps to help caregivers take care of themselves

Anxiety in German psychosomatic units: Long term extensive experience of treatment

Religious belief can reduce depression symptoms

Hudson Health Plan deploys Health Integrated Synergy Targeted Population Management program

Combination therapies effective for treating depression

Individuals with higher midlife BMI scores have lower cognitive ability: Study

Depression and stress hormone levels may lead to obesity in girls

State Round up: Utah struggling with state online health exchange; California cracks down on discount health plans

ViiV Healthcare highlights S/GSK1349572, SELZENTRY and EPZICOM for HIV/AIDS at 17th CROI

NCC, Pfizer provide over 10M units of ReFacto Antihemophilic Factor to underserved hemophilia patients

Behavioral Neuroscience: Adolescents more susceptible to internal and environmental factors

Strategies to reduce inappropriate treatment by clinicians

Obecure granted patent covering betahistine with olanzapine for mitigating antipsychotic drug associated weight gain

Role of behavioral health in pediatric IBD: NIHCD awards $500,000 grant to further study

Nation-wide study to assess risk of suicide among men

ResMed launches S9 sleep apnoea therapy platform in Europe

HHMI investigator to discuss how brain creates and controls emotions

Brain and tissue sample repository to help advance understanding and treatment of psychiatric diseases

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Depression News and Research

Latest Depression News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in